27742195|t|Mitochondrial dysfunction in obesity -related kidney disease: a novel therapeutic target
27742195|a|Lipid accumulation in renal cells has been implicated in the pathogenesis of obesity -related kidney disease, but the underlying mechanism is poorly understood. Szeto et al. now unravel a central role of mitochondrial dysfunction in a high fat diet -induced glomerulopathy and proximal tubular injury. Moreover, they demonstrate the renoprotective effect of SS31, a mitochondria - targeted antioxidant, in related models. Targeting mitochondria may offer a novel strategy for the therapy of obesity -related kidney disease.
27742195	0	25	Mitochondrial dysfunction	T033	C4021734
27742195	29	36	obesity	T047	C0028754
27742195	46	60	kidney disease	T047	C0022658
27742195	64	69	novel	T080	C0205314
27742195	70	81	therapeutic	T061	C0087111
27742195	82	88	target	T169	C1521840
27742195	89	107	Lipid accumulation	T033	C0333574
27742195	111	116	renal	T023	C0022646
27742195	117	122	cells	T025	C0007634
27742195	150	162	pathogenesis	T046	C0699748
27742195	166	173	obesity	T047	C0028754
27742195	183	197	kidney disease	T047	C0022658
27742195	218	227	mechanism	T169	C0441712
27742195	293	318	mitochondrial dysfunction	T033	C4021734
27742195	324	337	high fat diet	T061	C0521974
27742195	347	361	glomerulopathy	T047	C0268731
27742195	366	382	proximal tubular	T023	C0022677
27742195	383	389	injury	T037	C3263722
27742195	422	443	renoprotective effect	T033	C0243095
27742195	447	451	SS31	T116,T123	C1667754
27742195	455	467	mitochondria	T026	C0026237
27742195	470	478	targeted	T169	C1521840
27742195	479	490	antioxidant	T121	C0003402
27742195	503	509	models	T075	C0026336
27742195	511	520	Targeting	T169	C1521840
27742195	521	533	mitochondria	T026	C0026237
27742195	546	551	novel	T080	C0205314
27742195	569	576	therapy	T061	C0087111
27742195	580	587	obesity	T047	C0028754
27742195	597	611	kidney disease	T047	C0022658